Obviously, statistical analysis revealed a negative correlation of IL-17A levels with the augmentation of Foxp3+ Tregs in COPD patients' peripheral blood by SFC therapy. This evidence concerns the gene FOXP3 and chronic obstructive pulmonary disease.